Skip to main content

Seminars in Cancer Biology

  • ISSN: 1044-579X

Editor-In-Chief: Vincent

Next planned ship date: June 27, 2024

  • 5 Year impact factor: 14.9
  • Impact factor: 14.5

Seminars in Cancer Biology (YSCBI) is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology. Each issue is thematic in appro… Read more

Subscription options

Next planned ship date:
June 27, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Seminars in Cancer Biology (YSCBI) is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area.

The journal publishes topics including:

Role of glycation in different types of cancer

Immuno-Oncological Biomarkers

Epigenetics: solid tumors and haematological malignancies

Current Vision on target enzymes for cancer therapy

Translational Cancer Genomics

FOXO family in cancer

Emerging trends in biomarker discovery: ease of prognosis and prediction in cancer

Some chinks in Ras armor: novel cancer therapeutics on the horizon

Conference - Cancer Stem Cells: impact on treatment



Should you have a proposal or an idea for a thematic issue, please complete the thematic issue proposal form and send it to the Editorial Office (Ms. Carly Middendorp, [email protected]).